| The coma in glaucoma: Retinal ganglion cell dysfunction and recovery LE Fry, E Fahy, V Chrysostomou, F Hui, J Tang, P van Wijngaarden, ... Progress in retinal and eye research 65, 77-92, 2018 | 92 | 2018 |
| A retrospective survey of substance abuse in anaesthetists in Australia and New Zealand from 2004 to 2013 RA Fry, LE Fry, DJ Castanelli Anaesthesia and intensive care 43 (1), 111-117, 2015 | 65 | 2015 |
| RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences LE Fry, CF Peddle, AR Barnard, ME McClements, RE MacLaren International Journal of Molecular Sciences 21 (3), 777, 2020 | 50 | 2020 |
| CRISPR interference–potential application in retinal disease CF Peddle, LE Fry, ME McClements, RE MacLaren International journal of molecular sciences 21 (7), 2329, 2020 | 30 | 2020 |
| Analysis of pathogenic variants correctable with CRISPR base editing among patients with recessive inherited retinal degeneration LE Fry, ME McClements, RE MacLaren JAMA ophthalmology 139 (3), 319-328, 2021 | 28 | 2021 |
| Refractive outcomes of the Yamane flanged intrascleral haptic fixation technique JR Rocke, MB McGuinness, WK Atkins, LE Fry, JX Kane, DCA Fabinyi, ... Ophthalmology 127 (10), 1429-1431, 2020 | 22 | 2020 |
| Association of messenger RNA level with phenotype in patients with choroideremia: potential implications for gene therapy dose LE Fry, MI Patrício, J Williams, JW Aylward, H Hewitt, P Clouston, K Xue, ... JAMA ophthalmology 138 (2), 128-135, 2020 | 19 | 2020 |
| RNA-targeting strategies as a platform for ocular gene therapy S Kumar, LE Fry, JH Wang, KR Martin, AW Hewitt, FK Chen, GS Liu Progress in Retinal and Eye Research 92, 101110, 2023 | 17 | 2023 |
| Targeting retinal ganglion cell recovery JG Crowston, ET Fahy, L Fry, IA Trounce, P Van Wijngaarden, S Petrou, ... Eye 31 (2), 196-198, 2017 | 16 | 2017 |
| CRISPR genome engineering for retinal diseases A Kantor, ME McClements, CF Peddle, LE Fry, A Salman, ... Progress in Molecular Biology and Translational Science 182, 29-79, 2021 | 14 | 2021 |
| Substance use disorder amongst Australian and New Zealand anaesthetic trainees: an analysis of 30 years of data RA Fry, LE Fry, A Weeks Anaesthesia and Intensive Care 43 (4), 530, 2015 | 10 | 2015 |
| Promoter orientation within an AAV-CRISPR vector affects Cas9 expression and gene editing efficiency LE Fry, CF Peddle, M Stevanovic, AR Barnard, ME McClements, ... The CRISPR Journal 3 (4), 276-283, 2020 | 8 | 2020 |
| Expression of Rab Prenylation pathway genes and relation to disease progression in Choroideremia LE Fry, MI Patrício, JK Jolly, K Xue, RE MacLaren Translational Vision Science & Technology 10 (8), 12-12, 2021 | 6 | 2021 |
| What are we injecting with our drugs? AF Merry, DA Gargiulo, LE Fry Anaesthesia and Intensive Care 45 (5), 539-542, 2017 | 6 | 2017 |
| Is subretinal AAV gene replacement still the only viable treatment option for choroideremia? RC Han, LE Fry, A Kantor, ME McClements, K Xue, RE MacLaren Expert opinion on orphan drugs 9 (1), 13-24, 2021 | 5 | 2021 |
| Mitigation of stray magnetic fields in MICE V Bayliss, V Blackmore, J Cobb, M Courthold, L Fry, M George, P Hanlet, ... MICE Note 419, 2013 | 2 | 2013 |
| Comment on Di Giosaffatte et al. A Novel Hypothesis on Choroideremia-Manifesting Female Carriers: Could CHM In-Frame Variants Exert a Dominant Negative Effect? A Case Report … LE Fry, RE MacLaren Genes 14 (12), 2160, 2023 | 1 | 2023 |
| Comparison of CRISPR-Cas13 RNA editing tools for inherited retinal disease LE Fry, ME McClements, RE MacLaren Investigative Ophthalmology & Visual Science 63 (7), 3845-3845, 2022 | 1 | 2022 |
| Anesthetic substance abuse: international perspectives and parallels LE Fry, RA Fry Canadian Journal of Anesthesia/Journal canadien d'anesthésie 62, 1346-1347, 2015 | 1 | 2015 |
| Glass micro-particulate contamination of intravenous drugs–should we be using filter needles? L Fry Australian Medical Student Journal 6 (1), 2015 | 1 | 2015 |
